CD24 and breast carcinoma: In the MDA-MB-453 breast cancer cell line, expression of CD44 is very low and CD44+/CD24− subpopulation is not considered CSC subpopulation6, and this subpopulation significantly increases after treatment with 1 (Fig. 5C).